Clinical Trials Arena on MSN2d
OSE announces overall survival success in Phase II PDAC vaccine trialThe Phase II trial examined the therapeutic cancer vaccine Tedopi in combination with chemotherapy drug combination FOLFIRI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback